PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31427967-0	2019	Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism.	Hydroxychloroquine	0-18	insulin	Homo sapiens	47-54	
31427967-4	2019	Hydroxychloroquine has been suggested to have beneficial effects on lipids and insulin sensitivity, which may contribute in lowering high cardiovascular risk in SLE patients.	Hydroxychloroquine	0-18	insulin	Homo sapiens	79-86	
31427967-9	2019	The present results revealed that hydroxychloroquine reduced weight, hepatic steatosis, glucose, and insulin resistance.	Hydroxychloroquine	34-52	insulin	Homo sapiens	101-108